Clinical Trials List
Protocol NumberSPY123-202
Not yet recruiting
2026-05-01 - 2031-07-20
Phase II
-
Trial Applicant
TAIWAN PSI HEALTH DEVELOPMENT COMPANY LIMITED
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/06/01
Investigators and Locations
Co-Principal Investigator
- 陳介章 無
- 陳彥年 無
- SHU-CHEN WEI 無
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
12 participants
-
Global
645 participants
